Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07158034 · ClinicalTrials.gov registry record · NA

Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation

A NA study of Tinnitus, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07158034 is a NA study of Tinnitus that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 24 participants, below the 12,619-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07158034, a NA study of Tinnitus, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after six weeks of bi-modal stimulation.

Conditions Studied

Interventions

  • DEVICE Lenire Device

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-10-03
Est. Completion 2026-06-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07158034

The ClinicalTrials.gov registry entry for NCT07158034 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,619-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 1 intervention - of which Lenire Device is the first listed.

NCT07158034 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07158034 about?

NCT07158034 is a clinical study titled "Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation". The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after ...

What is the current status of trial NCT07158034?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-10-03. Estimated completion is 2026-06-30.

What conditions does trial NCT07158034 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT07158034?

The interventions under investigation include: Lenire Device (DEVICE).

Who is sponsoring clinical trial NCT07158034?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07158034 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.